Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NETWORK × Thymoma × Clear all

Phase

Phase 2 3 Phase NA 1

Status

Sponsor Class

OTHER 15 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Head and Neck Neoplasms 12 Colorectal Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Sarcoma 9 Prostatic Neoplasms 8 Uterine Cervical Neoplasms 7 Rectal Neoplasms 7 Leukemia 7 Colonic Neoplasms 7 Urinary Bladder Neoplasms 6 Stomach Neoplasms 6 Ovarian Neoplasms 6 Neoplasms 6 Lymphoma 6 Lung Neoplasms 6 Pain 5 Neoplasm Metastasis 5 Fallopian Tube Neoplasms 5 Brain Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Pancreatic Neoplasms 4 Hodgkin Disease 4 Central Nervous System Neoplasms 4 Burkitt Lymphoma 4 Breast Carcinoma In Situ 4 Testicular Neoplasms 3 Teratoma 3

Interventions

Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡